Form 8-K - Current report:
SEC Accession No. 0001104659-25-001492
Filing Date
2025-01-07
Accepted
2025-01-07 06:00:36
Documents
15
Period of Report
2025-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm252114d1_8k.htm   iXBRL 8-K 29825
2 EXHIBIT 99.1 tm252114d1_ex99-1.htm EX-99.1 20339
6 GRAPHIC tm252114d1_ex99-1img001.jpg GRAPHIC 14627
  Complete submission text file 0001104659-25-001492.txt   251476

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrna-20250107.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20250107_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20250107_pre.xml EX-101.PRE 22367
18 EXTRACTED XBRL INSTANCE DOCUMENT tm252114d1_8k_htm.xml XML 3657
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 25513358
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)